Effect of tetrahydrobiopterin on selective endothelial dysfunction of epicardial porcine coronary arteries induced by cardiopulmonary bypass

Eur J Cardiothorac Surg. 2006 Sep;30(3):464-71. doi: 10.1016/j.ejcts.2006.06.012. Epub 2006 Aug 1.

Abstract

Background: We hypothesized that cardiopulmonary bypass induces a selective alteration of the coronary arterial endothelial cell signal transduction which could be explained by a state of depletion and/or decreased activity of endogenous tetrahydrobiopterin (BH(4)). The aim of this study was to assess the effects of cardiopulmonary bypass and BH(4) on the endothelial function of epicardial coronary arteries in a swine model of cardiopulmonary bypass.

Methods: Swine underwent 90 min of cardiopulmonary bypass alone (N=19) or in association with a brief cardioplegic arrest with (N = 6) or without (N = 5) in vivo BH(4) administration, followed by a 60-min period following weaning from cardiopulmonary bypass and were compared to a control group (N = 7). Endothelium-dependent relaxations of epicardial coronary artery rings were studied using standard organ chamber experiments in the presence or absence of in vitro BH(4) or superoxide dismutase (SOD) and catalase.

Results: Cardiopulmonary bypass caused a statistically significant reduction of endothelium-dependent relaxations to serotonin (p < 0.0001), bradykinin (p < 0.001), UK14304 (p < 0.0001) and calcium ionophore (p < 0.01) in epicardial porcine coronary arteries. In vitro and in vivo BH(4) supplementation improved endothelium-dependent relaxations to serotonin and bradykinin, which were left unchanged by SOD-catalase administration. Cardiopulmonary bypass was associated with a decrease in nitric oxide availability (p = 0.002) and increased oxidative stress (p < 0.001), which were both restored by in vivo BH(4) administration (p < 0.001).

Conclusion: Treatment with BH(4) improves the endothelial dysfunction of porcine epicardial coronary arteries, restores nitric oxide availability and reduces the oxidative stress associated with cardiopulmonary bypass.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Biopterins / analogs & derivatives*
  • Biopterins / pharmacology
  • Bradykinin / pharmacology
  • Cardiopulmonary Bypass / adverse effects*
  • Coronary Vessels / drug effects*
  • Coronary Vessels / physiopathology
  • Cyclic GMP / analysis
  • Dose-Response Relationship, Drug
  • Endothelial Cells / drug effects*
  • Endothelial Cells / physiology
  • Endothelium, Vascular / drug effects
  • Endothelium, Vascular / physiopathology
  • Models, Animal
  • Muscle Contraction / drug effects
  • Muscle Contraction / physiology
  • Muscle Relaxation / drug effects
  • Muscle Relaxation / physiology
  • Muscle, Smooth, Vascular / drug effects
  • Muscle, Smooth, Vascular / physiopathology
  • Nitric Oxide / analysis
  • Nitric Oxide Synthase / metabolism
  • Oxidative Stress / drug effects
  • Oxidative Stress / physiology
  • Pericardium / drug effects
  • Pericardium / physiopathology
  • Serotonin / pharmacology
  • Serotonin Agents / pharmacology
  • Signal Transduction / drug effects
  • Signal Transduction / physiology
  • Superoxide Dismutase / pharmacology
  • Swine
  • Vasodilator Agents / pharmacology

Substances

  • Serotonin Agents
  • Vasodilator Agents
  • Biopterins
  • Nitric Oxide
  • Serotonin
  • Nitric Oxide Synthase
  • Superoxide Dismutase
  • sapropterin
  • Cyclic GMP
  • Bradykinin